Free

This is a FREE video, please log in to watch it and claim CPD.

Watch Now

To see members' videos, purchase a subscription and become a member today. 

Join Us

Back to Video List

Charlie Sayer - Immunotherapy, iRECIST and complications in NSCLC (in a post-COVID world) 11 Sep 2020

From the BIR's 2020 event 'Lung cancer imaging: Update for the not-so-new normal'.

Who should watch: A multidisciplinary audience consisting of radiologists, radiographers, advance practice providers, oncologists and pathologists.

Educational aims:
• To disseminate information on the general principles of lung cancer imaging
• To explore whether current imaging techniques, approaches and interpretation need to be modified

0.5 CPD credit.
Watch the video and complete the online self-reflection form. Go to "My events" to download your certificate. You must login to watch the video and receive CPD.

Duration:22 mins


Speaker info

Dr Charlie Sayer

Dr Charlie Sayer is a Consultant Radiologist with an interest in thoracic, head & neck and oncological imaging. He completed a 2 year fellowship in cardiothoracic and body imaging in London, UK. During this period he completed academic work in lung cancer surveillance imaging, pulmonary hypertension and interstitial lung disease. Presentations entitled Surveillance and Progression of Lung Cancer: Key concepts and New Directions and Lung Cancer Response Assessment: Beyond RECIST presented at the Radiological Society of North America (RSNA), in 2014 and 2017 were awarded Magna Cum Laude accolades. He has recently co-authored a book chapters and papers on lung nodule imaging, interstitial lung disease, pulmonary hypertension, lung cancer screening and pericystic lung cancer. Faculty for thoracic imaging education for the American College of Radiology and RSNA. He teaches as part of the Brighton and Sussex Medical School undergraduate and post-graduate programmes.